Published 22 hours ago • loading... • Updated 15 hours agoShow Less IconPopular Analysis Technique Hides Patient Variability in Alzheimer's Drug Trials Researchers said the method can turn weak amyloid-cognition signals into strong ones and made a failed solanezumab trial appear positive.Summary by News MedicalA statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.Share menu2 Articles2 ArticlesAllLeftCenter1RightSearch IconSort IconNews MedicalCenterFactualityOwnershipPopular analysis technique hides patient variability in Alzheimer's drug trialsA statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.15 hours ago·United StatesRead Full ArticleNeuroscience NewsFactualityOwnershipNew Math Method Inflates Alzheimer's Drug Success by 29xA critical research lette exposes severe flaws in "quantile aggregation", a statistical technique recently used by pharmaceutical researchers to evaluate the drug donanemab.22 hours agoRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources2Leaning Left0Leaning Right0Center1Last Updated15 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Untracked biasFactuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageNeuroscience News broke the news 22 hours ago on Monday, May 18, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsAlzheimer's Disease Plus IconAlzheimer's Disease Plus IconMedical Plus IconProvidence, Rhode Island Plus IconHealth & Medicine Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsAlzheimer's Disease Plus IconAlzheimer's Disease Plus IconMedical Plus IconProvidence, Rhode Island Plus IconHealth & Medicine Plus IconShow All